ArticleClinical and molecular hepatology2024

Metabolic-associated fatty liver disease is less effective in predicting mortality than non-alcoholic fatty liver disease and metabolic dysfunction-associated steatotic liver disease: Letter to the editor on "Prognosis of biopsy-confirmed metabolic dysfunction-associated steatotic liver disease: A sub-analysis of the CLIONE study".

Yixuan Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.